Compare XOMA & SNDL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | XOMA | SNDL |
|---|---|---|
| Founded | 1981 | 2006 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Pharmaceuticals and Biotechnology |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 457.6M | 432.6M |
| IPO Year | N/A | 2019 |
| Metric | XOMA | SNDL |
|---|---|---|
| Price | $30.49 | $1.68 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 1 |
| Target Price | ★ $69.50 | $5.00 |
| AVG Volume (30 Days) | 59.9K | ★ 1.9M |
| Earning Date | 11-12-2025 | 11-04-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.82 | N/A |
| Revenue | $47,106,000.00 | ★ $683,170,243.00 |
| Revenue This Year | $77.23 | $5.48 |
| Revenue Next Year | $17.97 | $3.10 |
| P/E Ratio | $37.11 | ★ N/A |
| Revenue Growth | ★ 118.02 | 4.43 |
| 52 Week Low | $18.35 | $1.15 |
| 52 Week High | $39.92 | $2.89 |
| Indicator | XOMA | SNDL |
|---|---|---|
| Relative Strength Index (RSI) | 41.66 | 37.79 |
| Support Level | $29.60 | $1.57 |
| Resistance Level | $31.44 | $1.77 |
| Average True Range (ATR) | 1.51 | 0.07 |
| MACD | -0.08 | 0.02 |
| Stochastic Oscillator | 32.61 | 46.99 |
XOMA Royalty Corp is a biotechnology royalty aggregator playing a role in helping biotech companies achieve their goal of improving human health. XOMA acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceuticals or biotechnology companies. XOMA acquires future economic rights, the seller receives non-dilutive, non-recourse funding that can use to advance their internal drug candidate(s) or for general corporate purposes. Geographically, the company operates in Switzerland, United States, Asia Pacific, Europe and Others.
SNDL Inc is a private-sector liquor and cannabis retailer in Canada with retail banners that include Ace Liquor, Wine and Beyond, Liquor Depot, Value Buds, and Spiritleaf. The principal activities of the company are the retailing of wines, beers, and spirits. It comprised four reportable segments: liquor retail, cannabis retail, cannabis operations, and investments. Liquor retail includes the sale of wines, beers, and spirits through owned liquor stores. The company generates maximum revenue from liquor retail.